Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer

CD24脂筏与妇科肿瘤耐药性分析

• 批准号: 16K11165
• 负责人: Tanaka Yoshimichi
• 金额: $ 3万
• 依托单位: Osaka Medical College
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2016
• 资助国家: 日本
• 起止时间: 2016-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K11165/
• 关键词: CD24; EMT; lipid raft; 化学療法抵抗性; 卵巣癌; 子宮内膜癌; MET; ＣＤ２４; ＥＭＴ; 婦人科悪性腫瘍; ＧＰＩアンカー型タンパク質; ラフト形成; 婦人科癌; ＧＰＩアンカー型蛋白質

项目成果

Association of matrix metalloproteinase?9 and decorin expression with the infiltration of cervical cancer

基质金属蛋白酶9和核心蛋白聚糖表达与宫颈癌浸润的关系

• DOI: 10.3892/ol.2018.9713
• 发表时间: 2018
• 期刊: Oncology Letters
• 影响因子: 2.9
• 作者: Tanaka Tomohito;Terai Yoshito;Ohmichi Masahide
• 通讯作者: Ohmichi Masahide

Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency ? The leading cause of preeclampsia

重组人可溶性血栓调节蛋白作为抗凝治疗可改善复发性流产和胎盘功能不全导致的胎儿生长受限？

• DOI: 10.1016/j.placenta.2018.03.006
• 发表时间: 2018
• 期刊: Placenta
• 影响因子: 3.8
• 作者: Sano Takumi;Terai Yoshito;Daimon Atsushi;Nunode Misa;Nagayasu Yoko;Okamoto Atsuko;Fujita Daisuke;Hayashi Masami;Ohmichi Masahide
• 通讯作者: Ohmichi Masahide

Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer.

• DOI: 10.18632/oncotarget.25232
• 发表时间: 2018-04-27
• 期刊: Oncotarget
• 作者: Kogata Y;Tanaka T;Ono YJ;Hayashi M;Terai Y;Ohmichi M
• 通讯作者: Ohmichi M

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.

• DOI: 10.3892/or.2017.5583
• 发表时间: 2017-06
• 期刊: Oncology reports
• 影响因子: 4.2
• 作者: Nakamura K;Terai Y;Tanabe A;Ono YJ;Hayashi M;Maeda K;Fujiwara S;Ashihara K;Nakamura M;Tanaka Y;Tanaka T;Tsunetoh S;Sasaki H;Ohmichi M
• 通讯作者: Ohmichi M